Le Gouill S - Search Results

1

The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma.

Touzeau C, Dousset C, Le Gouill S, Sampath D, Leverson JD, Souers AJ, Maïga S, Béné MC, Moreau P, Pellat-Deceunynck C, Amiot M. Touzeau C, et al. Among authors: le gouill s. Leukemia. 2014 Jan;28(1):210-2. doi: 10.1038/leu.2013.216. Epub 2013 Jul 17. Leukemia. 2014. PMID: 23860449 Free PMC article. No abstract available.

2

[Pseudallescheria boydii osteoarthritis in a patient with acute lymphoblastic leukemia: a case report].

Le Gouill SL, Morineau N, Miégeville M, Milpied N, Harousseau JL, Moreau P. Le Gouill SL, et al. Rev Med Interne. 1999 May;20(5):434-8. doi: 10.1016/s0248-8663(99)83097-5. Rev Med Interne. 1999. PMID: 10365416 French.

3

Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia.

Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, Harousseau JL, Bataille R, Avet-Loiseau H. Le Gouill S, et al. J Clin Oncol. 2000 Apr;18(7):1533-8. doi: 10.1200/JCO.2000.18.7.1533. J Clin Oncol. 2000. PMID: 10735902

4

Tandem high-dose therapy followed by autologous stem-cell transplantation for refractory or relapsed high grade non-Hodgkin's lymphoma with poor prognosis factors: a prospective pilot study.

Le Gouill S, Moreau P, Morineau N, Harousseau JL, Milpied N. Le Gouill S, et al. Haematologica. 2002 Mar;87(3):333-4. Haematologica. 2002. PMID: 11869953

5

Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells.

Le Gouill S, Pellat-Deceunynck C, Harousseau JL, Rapp MJ, Robillard N, Bataille R, Amiot M. Le Gouill S, et al. Leukemia. 2002 Sep;16(9):1664-7. doi: 10.1038/sj.leu.2402629. Leukemia. 2002. PMID: 12200678

6

VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis.

Le Gouill S, Podar K, Amiot M, Hideshima T, Chauhan D, Ishitsuka K, Kumar S, Raje N, Richardson PG, Harousseau JL, Anderson KC. Le Gouill S, et al. Blood. 2004 Nov 1;104(9):2886-92. doi: 10.1182/blood-2004-05-1760. Epub 2004 Jun 24. Blood. 2004. PMID: 15217829 Free article.

7

Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.

Wuillème-Toumi S, Robillard N, Gomez P, Moreau P, Le Gouill S, Avet-Loiseau H, Harousseau JL, Amiot M, Bataille R. Wuillème-Toumi S, et al. Among authors: le gouill s. Leukemia. 2005 Jul;19(7):1248-52. doi: 10.1038/sj.leu.2403784. Leukemia. 2005. PMID: 15902294

8

Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex.

Gomez-Bougie P, Oliver L, Le Gouill S, Bataille R, Amiot M. Gomez-Bougie P, et al. Among authors: le gouill s. Oncogene. 2005 Dec 1;24(54):8076-9. doi: 10.1038/sj.onc.1208949. Oncogene. 2005. PMID: 16091744

9

Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells.

Menoret E, Gomez-Bougie P, Geffroy-Luseau A, Daniels S, Moreau P, Le Gouill S, Harousseau JL, Bataille R, Amiot M, Pellat-Deceunynck C. Menoret E, et al. Among authors: le gouill s. Blood. 2006 Aug 15;108(4):1346-52. doi: 10.1182/blood-2005-12-007971. Epub 2006 Apr 25. Blood. 2006. PMID: 16638930 Free article.

10

Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.

Romagnoli M, Desplanques G, Maïga S, Legouill S, Dreano M, Bataille R, Barillé-Nion S. Romagnoli M, et al. Clin Cancer Res. 2007 Oct 15;13(20):6010-8. doi: 10.1158/1078-0432.CCR-07-0140. Clin Cancer Res. 2007. PMID: 17947462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters